DK2201002T3 - 5-HT7-receptorantagonister - Google Patents

5-HT7-receptorantagonister

Info

Publication number
DK2201002T3
DK2201002T3 DK08836911.1T DK08836911T DK2201002T3 DK 2201002 T3 DK2201002 T3 DK 2201002T3 DK 08836911 T DK08836911 T DK 08836911T DK 2201002 T3 DK2201002 T3 DK 2201002T3
Authority
DK
Denmark
Prior art keywords
receptor antagonists
migraine
formula
treatment
present
Prior art date
Application number
DK08836911.1T
Other languages
Danish (da)
English (en)
Inventor
Valentina O Badescu
Sandra Ann Filla
Peter Thaddeus Gallagher
Maria Ann Whatton
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK2201002T3 publication Critical patent/DK2201002T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK08836911.1T 2007-10-12 2008-09-30 5-HT7-receptorantagonister DK2201002T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US97946407P 2007-10-12 2007-10-12
PCT/US2008/078294 WO2009048765A1 (en) 2007-10-12 2008-09-30 5-ht7 receptor antagonists

Publications (1)

Publication Number Publication Date
DK2201002T3 true DK2201002T3 (da) 2012-04-10

Family

ID=40134870

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08836911.1T DK2201002T3 (da) 2007-10-12 2008-09-30 5-HT7-receptorantagonister

Country Status (19)

Country Link
US (1) US7910588B2 (OSRAM)
EP (1) EP2201002B1 (OSRAM)
JP (1) JP5291716B2 (OSRAM)
KR (1) KR101161070B1 (OSRAM)
CN (1) CN101821257B (OSRAM)
AT (1) ATE548365T1 (OSRAM)
AU (1) AU2008311154B2 (OSRAM)
BR (1) BRPI0818450A2 (OSRAM)
CA (1) CA2699674C (OSRAM)
CY (1) CY1112709T1 (OSRAM)
DK (1) DK2201002T3 (OSRAM)
EA (1) EA016787B1 (OSRAM)
ES (1) ES2380756T3 (OSRAM)
HR (1) HRP20120257T1 (OSRAM)
MX (1) MX2010003986A (OSRAM)
PL (1) PL2201002T3 (OSRAM)
PT (1) PT2201002E (OSRAM)
SI (1) SI2201002T1 (OSRAM)
WO (1) WO2009048765A1 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI396857B (zh) * 2009-12-30 2013-05-21 Etron Technology Inc 晶片測試電路
EP2766353B1 (en) 2011-10-11 2015-06-17 UCB Pharma, S.A. 2-oxo-piperidinyl derivatives
ES2804545T3 (es) 2013-03-11 2021-02-08 Univ Temple Nuevos moduladores de la actividad del receptor de 5-hidroxitriptamina 7 y su método de uso
TW201601632A (zh) * 2013-11-20 2016-01-16 杜邦股份有限公司 1-芳基-3-烷基吡唑殺蟲劑
US10544117B2 (en) 2014-09-10 2020-01-28 Temple University—Of the Commonwealth System of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
IL309982A (en) 2016-11-15 2024-03-01 Univ Temple New modulators of 5-hydroxytryptamine receptor 7 and a method of using them
US11220505B2 (en) 2017-03-21 2022-01-11 Temple University-Of The Commonwealth System Of Higher Education 5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6465467B1 (en) * 1999-05-21 2002-10-15 Biovitrum Ab Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
US20030008880A1 (en) 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
MXPA05008137A (es) * 2003-01-31 2005-09-30 Pfizer Prod Inc Antagonistas y agonistas de 5ht7.
US7211783B2 (en) 2004-01-09 2007-05-01 Tamperproof Container Licensing Corp. Tamper-proof container
JP2008501031A (ja) 2004-05-28 2008-01-17 バーテックス ファーマシューティカルズ インコーポレイテッド ムスカリン受容体のモジュレーター
TW200914020A (en) * 2007-08-28 2009-04-01 Lilly Co Eli Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists

Also Published As

Publication number Publication date
AU2008311154A1 (en) 2009-04-16
HRP20120257T1 (hr) 2012-04-30
CA2699674C (en) 2013-07-16
CA2699674A1 (en) 2009-04-16
US7910588B2 (en) 2011-03-22
AU2008311154B2 (en) 2013-09-26
CN101821257B (zh) 2013-05-22
ES2380756T3 (es) 2012-05-18
JP2011500575A (ja) 2011-01-06
EP2201002B1 (en) 2012-03-07
EA016787B1 (ru) 2012-07-30
CY1112709T1 (el) 2016-02-10
JP5291716B2 (ja) 2013-09-18
SI2201002T1 (sl) 2012-04-30
PT2201002E (pt) 2012-04-27
KR101161070B1 (ko) 2012-07-13
BRPI0818450A2 (pt) 2015-05-12
CN101821257A (zh) 2010-09-01
PL2201002T3 (pl) 2012-07-31
WO2009048765A1 (en) 2009-04-16
EA201070462A1 (ru) 2010-10-29
EP2201002A1 (en) 2010-06-30
MX2010003986A (es) 2010-04-27
ATE548365T1 (de) 2012-03-15
US20100197700A1 (en) 2010-08-05
KR20100054853A (ko) 2010-05-25

Similar Documents

Publication Publication Date Title
ATE394400T1 (de) Bicyclische anilidspirohydantoine als cgrp- rezeptorantagonisten
DE602005020655D1 (de) Carboxamid-spirolactam-cgrp-rezeptor-antagonisten
EP1605936A4 (en) ARYL-spiro hydantoin-CGRP Receptor Antagonists
EP1861399A4 (en) CGRP RECEPTOR ANTAGONISTS
NO20072435L (no) CGRP-reseptorantagonister
JO2355B1 (en) Hereditary calcitonin polypeptide receptor antagonists
ATE556060T1 (de) Monocyclische anilidspirohydantoine als cgrp- rezeptorantagonisten
MY165113A (en) Piperidinone carboxamide azaindane cgrp receptor antagonists
ATE535514T1 (de) Carboxamid-spirohydantoin-cgrp-rezeptor- antagonisten
ATE509019T1 (de) Benzodiazepinspirohydantoine als cgrp- rezeptorantagonisten
DE602004012858D1 (de) 2-aminobenzothiazole als cb1 rezeptor inverse agonisten
CY1112709T1 (el) Ανταγωνιστες υποδοχεα 5-ητ7
ATE493412T1 (de) Spirohydantoin-aryl-cgrp-rezeptorantagonisten
ATE520668T1 (de) Sigmarezeptor-inhibitoren
ATE542795T1 (de) Benzylpiperazinderivate als motilin- rezeptorantagonisten
DE602005027230D1 (de) Cgrp-rezeptorantagonisten
DE602005027870D1 (de) Cgrp-rezeptorantagonisten
ATE466853T1 (de) Cgrp-rezeptorantagonisten
DE602007004327D1 (de) Einen azepin-kern enthaltende antagonisten des histaminrezeptors
ATE525370T1 (de) Phthalazin- und pyridoä3,4- düpyridazinverbindungen als h1-rezeptor- antagonisten
ATE525360T1 (de) Neuartige imidazolinylmethyl-aryl-sulfonamide
ATE531697T1 (de) Neuartige imidazolinylmethyl-aryl-sulfonamide
TN2013000179A1 (en) Piperidinone carboxamide azaindane cgrp receptor antagonists
UA109463C2 (xx) Піперидинонкарбоксамідазаіндани - антагоністи рецептора cgrp